STARD4 suppresses tumorigenesis and attenuates enzalutamide resistance via lipid metabolic reprogramming and AR stabilization in prostate cancer
STARD4通过脂质代谢重编程和AR稳定作用抑制前列腺癌的肿瘤发生并减弱恩扎卢胺耐药性。
期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03600-7
Zhang, Yi; Wang, Xi; Wang, Jiuyi; Ma, Ke; Jia, Lei; Liu, Bo; Yuan, Xianglin; Li, Qiang; Wang, Qinzhang; Li, Qinyu; Zeng, Kai